EcoDrugPlus

Tachykinin Receptor 1

Ensembl ID : ENSAMXG00000030275
Gene Symbol: TACR1
1 Cross references
215 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSAMXG00000012832
Gene Symbol: TACR2
1 Cross references
197 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSAMXG00000005217
Gene Symbol: TACR3
3 Cross references
141 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSAMXG00000042832
Gene Symbol: TERT
1 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSAMXG00000001025
Gene Symbol: TBXAS1
1 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSAMXG00000021585
Gene Symbol: TBXA2R
3 Cross references
193 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSAMXG00000007245
Gene Symbol: TYMS
1 Cross references
225 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSAMXG00000035362
Gene Symbol: TRHR
4 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSAMXG00000035218
Gene Symbol: LOC103029490
3 Cross references
194 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSAMXG00000026060
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSAMXG00000037614
Gene Symbol: TLR2
1 Cross references
209 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSAMXG00000025582
Gene Symbol: TLR2
1 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).